nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis
|
Lorentzon, Mattias |
|
2019 |
36 |
10 |
p. 2811-2824 |
artikel |
2 |
Anterior Chamber Inflammation After Cataract Surgery: A Randomized Clinical Trial Comparing Bromfenac 0.09% to Dexamethasone 0.1%
|
Coassin, Marco |
|
2019 |
36 |
10 |
p. 2712-2722 |
artikel |
3 |
Burden of Asthma and Role of 2.5 µg Tiotropium Respimat® as an Add-On Therapy: A Systematic Review of Phase 2/3 Trials
|
Mansfield, Lyndon |
|
2019 |
36 |
10 |
p. 2587-2599 |
artikel |
4 |
Burden of Asthma and Role of 2.5 µg Tiotropium Respimat® as an Add-On Therapy: A Systematic Review of Phase 2/3 Trials
|
Mansfield, Lyndon |
|
|
36 |
10 |
p. 2587-2599 |
artikel |
5 |
Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
|
Glassberg, Marilyn K. |
|
2019 |
36 |
10 |
p. 2910-2926 |
artikel |
6 |
Correction to: Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
|
Glassberg, Marilyn K. |
|
2019 |
36 |
10 |
p. 2927-2929 |
artikel |
7 |
Effect of Empagliflozin on Free Fatty Acids and Ketone Bodies in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial
|
Nishimura, Rimei |
|
2019 |
36 |
10 |
p. 2769-2782 |
artikel |
8 |
Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally
|
Zubiaur, Pablo |
|
2019 |
36 |
10 |
p. 2744-2755 |
artikel |
9 |
Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
|
Arora, Sanjeevani |
|
2019 |
36 |
10 |
p. 2638-2678 |
artikel |
10 |
Exploration of Different Rehabilitation Routes for Sepsis Survivors with Monitoring of Health Status and Quality of Life: RehaSep Trial Protocol
|
Wójcik, Barbara |
|
2019 |
36 |
10 |
p. 2968-2978 |
artikel |
11 |
Generalizability of Cardiovascular Safety Trials on SGLT2 Inhibitors to the Real World: Implications for Clinical Practice
|
Nicolucci, Antonio |
|
2019 |
36 |
10 |
p. 2895-2909 |
artikel |
12 |
Health Outcomes Among Patients Diagnosed with Schizophrenia in the US Veterans Health Administration Population Who Transitioned from Once-Monthly to Once-Every-3-Month Paliperidone Palmitate: An Observational Retrospective Analysis
|
Patel, Charmi |
|
2019 |
36 |
10 |
p. 2941-2953 |
artikel |
13 |
Hematopoietic Stem Cell Transplantation and Brentuximab Vedotin for Patients with Relapsed or Refractory Hodgkin Lymphoma and Systemic Anaplastic Large-Cell Lymphoma
|
Ishizawa, Kenichi |
|
2019 |
36 |
10 |
p. 2679-2696 |
artikel |
14 |
Humanistic and Economic Impact of Moderate to Severe Plaque Psoriasis in Brazil
|
Lopes, Nilcéia |
|
2019 |
36 |
10 |
p. 2849-2865 |
artikel |
15 |
Indirect Treatment Comparison of Nivolumab Versus Observation or Ipilimumab as Adjuvant Therapy in Resected Melanoma Using Pooled Clinical Trial Data
|
Freeman, Morganna |
|
2019 |
36 |
10 |
p. 2783-2796 |
artikel |
16 |
Individual Patient Data Meta-Analysis from 16 Trials for Safety Factors in Cytokine Release Syndrome After CAR-T Therapy in Patients with Non-Hodgkin Lymphoma (NHL) and Acute Lymphoblastic Leukemia
|
Li, Jie |
|
2019 |
36 |
10 |
p. 2881-2894 |
artikel |
17 |
Is Dipstick Urinalysis Screening Beneficial in Men with Lower Urinary Tract Symptoms?
|
Lowe, Franklin C. |
|
2019 |
36 |
10 |
p. 2954-2967 |
artikel |
18 |
Long-Term Efficacy and Safety of Linagliptin in a Japanese Population with Type 2 Diabetes Aged ≥ 60 Years Treated with Basal Insulin: A Randomised Trial
|
Araki, Eiichi |
|
2019 |
36 |
10 |
p. 2697-2711 |
artikel |
19 |
Maintenance Versus Intermittent Strategies in the Treatment of Metastatic Colorectal Cancer: A Meta-Analysis from Another Angle
|
Ji, Xiaohui |
|
2019 |
36 |
10 |
p. 2838-2848 |
artikel |
20 |
One-Year Comparative Evaluation of iStent or iStent inject Implantation Combined with Cataract Surgery in a Single Center
|
Guedes, Ricardo Augusto Paletta |
|
2019 |
36 |
10 |
p. 2797-2810 |
artikel |
21 |
Oral Corticosteroid Use for the Treatment of Chronic Eosinophilic Disease: A Patient’s and His Physician’s Experience
|
Silva, Mitchell |
|
2019 |
36 |
10 |
p. 2558-2566 |
artikel |
22 |
Pharmacokinetics and Bioequivalence of Memantine Tablet and a New Dry Syrup Formulation in Healthy Japanese Males: Two Single-Dose Crossover Studies
|
Maekawa, Yutaro |
|
2019 |
36 |
10 |
p. 2930-2940 |
artikel |
23 |
Pharmacokinetics of Total and Unbound Paclitaxel After Administration of Paclitaxel Micellar or Nab-Paclitaxel: An Open, Randomized, Cross-Over, Explorative Study in Breast Cancer Patients
|
Borgå, Olof |
|
2019 |
36 |
10 |
p. 2825-2837 |
artikel |
24 |
Pharmacokinetics of Total and Unbound Paclitaxel After Administration of Paclitaxel Micellar or Nab-Paclitaxel: An Open, Randomized, Cross-Over, Explorative Study in Breast Cancer Patients
|
Borgå, Olof |
|
|
36 |
10 |
p. 2825-2837 |
artikel |
25 |
Prognostic Role of Ki-67 in Adrenocortical Carcinoma After Primary Resection: A Retrospective Mono-Institutional Study
|
Zhang, Fuxun |
|
2019 |
36 |
10 |
p. 2756-2768 |
artikel |
26 |
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)
|
Incorvaia, Lorena |
|
2019 |
36 |
10 |
p. 2600-2617 |
artikel |
27 |
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)
|
Incorvaia, Lorena |
|
|
36 |
10 |
p. 2600-2617 |
artikel |
28 |
Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes
|
Handelsman, Yehuda |
|
2019 |
36 |
10 |
p. 2567-2586 |
artikel |
29 |
Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes
|
Handelsman, Yehuda |
|
|
36 |
10 |
p. 2567-2586 |
artikel |
30 |
Symptoms and Quality of Life in Patients with Fabry Disease: Results from an International Patient Survey
|
Morand, Olivier |
|
2019 |
36 |
10 |
p. 2866-2880 |
artikel |
31 |
Thyroid Surgery: Whose Domain Is It?
|
Zbären, Peter |
|
2019 |
36 |
10 |
p. 2541-2546 |
artikel |
32 |
Towards an Effective and Safe Treatment of Inflammatory Pain: A Delphi-Guided Expert Consensus
|
Varrassi, Giustino |
|
2019 |
36 |
10 |
p. 2618-2637 |
artikel |
33 |
Towards an Effective and Safe Treatment of Inflammatory Pain: A Delphi-Guided Expert Consensus
|
Varrassi, Giustino |
|
|
36 |
10 |
p. 2618-2637 |
artikel |
34 |
Understanding Dry Powder Inhalers: Key Technical and Patient Preference Attributes
|
Levy, Mark L. |
|
2019 |
36 |
10 |
p. 2547-2557 |
artikel |
35 |
Understanding the Patient Perception of Statin Experience: A Qualitative Study
|
Vrablik, Michal |
|
2019 |
36 |
10 |
p. 2723-2743 |
artikel |